{"id":"artesunate-lapdap","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal disturbances"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Hemolytic anemia (in G6PD-deficient patients)"}]},"_chembl":{"chemblId":"CHEMBL361497","moleculeType":"Small molecule","molecularWeight":"384.43"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Artesunate acts as a fast-acting blood schizonticide that rapidly reduces parasite biomass, while lapdap (chlorproguanil-dapsone) inhibits folate metabolism in the parasite, preventing DNA synthesis. The combination provides both rapid parasite clearance and sustained suppression, with potential for reduced resistance development compared to monotherapy.","oneSentence":"Artesunate-lapdap is a fixed-dose combination that combines an artemisinin derivative with a diaminopyrimidine antifolate to kill malaria parasites through complementary mechanisms.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:42:33.832Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Uncomplicated malaria caused by Plasmodium falciparum"},{"name":"Malaria treatment in endemic regions"}]},"trialDetails":[{"nctId":"NCT00119145","phase":"PHASE4","title":"Kintampo Trial of Combination Therapy for Malaria","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2005-06","conditions":"Malaria","enrollment":510},{"nctId":"NCT00519467","phase":"PHASE2","title":"Safety and Efficacy Dose of Artesunate Used in Combination With LAPDAP Treatment of Uncomplicated Falciparum Malaria","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2003-06","conditions":"Malaria","enrollment":120},{"nctId":"NCT00371735","phase":"PHASE3","title":"Chlorproguanil-Dapsone-Artesunate (CDA) Versus Chlorproguanil-Dapsone (LAPDAP) For Uncomplicated Malaria","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-04","conditions":"Malaria, Falciparum","enrollment":900},{"nctId":"NCT00393679","phase":"PHASE3","title":"Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African Children","status":"COMPLETED","sponsor":"Institute of Tropical Medicine, Belgium","startDate":"2007-07","conditions":"Fever, Malaria","enrollment":4112},{"nctId":"NCT00164359","phase":"PHASE4","title":"Amodiaquine Plus Artesunate Versus Lapdap Plus Artesunate in the Treatment of Uncomplicated P. Falciparum Malaria in Malawi","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2005-04","conditions":"Malaria, Falciparum","enrollment":212},{"nctId":"NCT00461578","phase":"NA","title":"Tolerability and Efficacy of CD+A Compared to AQ+SP for the Treatment of P.Falciparum Malaria in Rwandan Children","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2005-04","conditions":"Malaria","enrollment":800}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"artesunate-lapdap","genericName":"artesunate-lapdap","companyName":"London School of Hygiene and Tropical Medicine","companyId":"london-school-of-hygiene-and-tropical-medicine","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Artesunate-lapdap is a fixed-dose combination that combines an artemisinin derivative with a diaminopyrimidine antifolate to kill malaria parasites through complementary mechanisms. Used for Uncomplicated malaria caused by Plasmodium falciparum, Malaria treatment in endemic regions.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}